However, anything that alters saliva production, oral pH, or blood flow to the oral mucosa could theoretically affect GLP-1 drop absorption
Mounjaro (tirzepatide) is a once-weekly subcutaneous injection that activates two gut hormone receptors at once, GIP and GLP-1, to suppress appetite, slow gastric emptying, improve insulin sensitivity, and increase energy use
Tracking response 8 to 12 weeks into a protocol: Build Your Own with ALT, AST, GGT, hsCRP, and homocysteine to confirm the protocol is moving downstream markers in the right direction
Soluble fiber is recommended by the International Foundation for Gastrointestinal Disorders as a bulking agent to reduce watery stool
Newborn TSH can be used as an indicator of population iodine status